Proseek single-plex protein assay kit system to detect sAxl and Gas6 in serological material of brain tumor patients
- PMID: 29876303
- PMCID: PMC5989588
- DOI: 10.1016/j.btre.2018.e00252
Proseek single-plex protein assay kit system to detect sAxl and Gas6 in serological material of brain tumor patients
Erratum in
-
Erratum regarding missing Declaration of Competing Interest statements in previously published articles.Biotechnol Rep (Amst). 2021 Mar 19;29:e00582. doi: 10.1016/j.btre.2020.e00582. eCollection 2021 Mar. Biotechnol Rep (Amst). 2021. PMID: 33786326 Free PMC article.
Abstract
•The receptor tyrosine kinase (RTK) Axl and its ligand Gas6 are critically involved in the pathogenesis of high-grade glioma (HGG). Both proteins were found to be overexpressed e.g. in tumor cells, mediating cell proliferation and migration as well as tumor angiogenesis and neuroinflammation. The extracellular domain of Axl (sAxl) and Gas6 were found in the peri-tumoral edema and blood of animals as well as in human glioma tissue. Therefore, we monitored the level of sAxl and Gas6 in human blood samples. To increase the sensitivity of protein detection beyond commonly used standard methods we preliminary tested the innovative Proseek Single-Plex Protein Assay Kit System from Olink Bioscience together with new antibodies against the soluble RTK sAxl and its ligand Gas6. We conclude that the Proseek method is a highly sensitive and fast procedure that can be used as a possible powerful tool compared to routinely used ELISA-methods.
Keywords: Gas6; High-grade glioma (HGG); Proseek; Proximity extension assay (PEA); Serum; sAxl.
Figures
References
-
- Sanai N., Alcarez-Buylla A., Berger M.S. Neural stem cells and the origin of gliomas. New Engl. J. Med. 2005;353:811–822. - PubMed
-
- Louis D.N., Perry A., Reifenberger G. The 2016 World Health Organisation classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131:803–820. - PubMed
-
- Stupp R., Mason W.P., van den Bent M.J. Radiotherapy plus concomitant and aduvant temozolomide for glioblastoma. Engl. J. Med. 2005;352:987–996. - PubMed
-
- Stupp R., Tailibert S., Kesari S. Maintenance therapy with tumor-treating fields plus temozolmide vs temozolomide alone for glioblastoma: a randomized clinical trial. JAMA. 2015;14:2535–2543. - PubMed
-
- Hutterer M., Kzyazev P., Abate A. Axl and growth arrest –specific Gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme. Clin. Cancer Res. 2008;14:130–138. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous